Bessemer Group Inc. Boosts Stock Position in SPDR S&P Biotech ETF $XBI

Bessemer Group Inc. increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.5% in the fourth quarter, HoldingsChannel reports. The firm owned 1,853,232 shares of the exchange traded fund’s stock after buying an additional 220,244 shares during the quarter. Bessemer Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $225,965,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XBI. JPMorgan Chase & Co. increased its position in SPDR S&P Biotech ETF by 27.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after purchasing an additional 2,900,633 shares in the last quarter. Assetmark Inc. increased its position in SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after purchasing an additional 635,782 shares in the last quarter. Greenwoods Asset Management Hong Kong Ltd. purchased a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth about $55,613,000. Ameriprise Financial Inc. increased its position in SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares in the last quarter. Finally, Meitav Investment House Ltd. increased its position in SPDR S&P Biotech ETF by 70.3% during the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after purchasing an additional 281,602 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.7%

SPDR S&P Biotech ETF stock opened at $134.85 on Friday. The stock has a market cap of $8.60 billion, a PE ratio of 11.47 and a beta of 0.85. The stock has a 50-day moving average price of $129.30 and a 200 day moving average price of $124.37. SPDR S&P Biotech ETF has a 52 week low of $75.71 and a 52 week high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.